Cargando…

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study

BACKGROUND: The pathophysiology of psychosis is incompletely understood. Disruption in cortical glutamatergic signalling causing aberrant striatal dopamine synthesis capacity is a proposed model for psychosis, but has not been tested in vivo. We therefore aimed to test the relationship between corti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jauhar, Sameer, McCutcheon, Robert, Borgan, Faith, Veronese, Mattia, Nour, Matthew, Pepper, Fiona, Rogdaki, M, Stone, James, Egerton, Alice, Turkheimer, Frederico, McGuire, Philip, Howes, Oliver D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162342/ https://www.ncbi.nlm.nih.gov/pubmed/30236864 http://dx.doi.org/10.1016/S2215-0366(18)30268-2

Ejemplares similares

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

M149. THE TOPOGRAPHY OF STRIATAL DOPAMINE AND SYMPTOMS IN PSYCHOSIS: AN INTEGRATIVE PET AND MRI STUDY
por: McCutcheon, Rob, et al.
Publicado: (2020)

The Topography of Striatal Dopamine and Symptoms in Psychosis: An Integrative Positron Emission Tomography and Magnetic Resonance Imaging Study
por: McCutcheon, Robert A., et al.
Publicado: (2020)

Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study
por: Borgan, Faith R., et al.
Publicado: (2019)

S172. GLUTAMATE RELATED CONNECTIVITY DISTURBANCES OF THE SALIENCE AND DEFAULT MODE NETWORKS IN PSYCHOSIS
por: McCutcheon, Rob, et al.
Publicado: (2020)

O3.5. TESTING THE DOPAMINE HYPOTHESIS OF PSYCHOSIS USING POSITRON EMISSION TOMOGRAPHIC IMAGING IN FIRST EPISODE BIPOLAR AFFECTIVE DISORDER AND SCHIZOPHRENIA
por: Jauhar, Sameer, et al.
Publicado: (2018)

The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
por: Jauhar, Sameer, et al.
Publicado: (2019)

The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A (1)H-MRS study in first-episode psychosis patients
por: Zahid, Uzma, et al.
Publicado: (2022)

Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study
por: Jauhar, Sameer, et al.
Publicado: (2018)

The relationship between grey matter volume and striatal dopamine function in psychosis: a multi-modal (18)F-DOPA PET and voxel-based morphometry study
por: D’Ambrosio, Enrico, et al.
Publicado: (2021)

S181. THE STATE OR TRAIT COMPONENT OF DOPAMINE AND GLUTAMATE DYSFUNCTION IN THE RISK FOR PSYCHOSIS: AN IN VIVO MULTIMODAL IMAGING STUDY OF INDIVIDUALS WITH 22Q11.2 DELETION
por: Rogdaki, Maria, et al.
Publicado: (2018)

The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study
por: Rogeau, Antoine, et al.
Publicado: (2022)

Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study
por: McCutcheon, Robert A., et al.
Publicado: (2019)

Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study
por: Rogdaki, Maria, et al.
Publicado: (2021)

N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
por: Modinos, Gemma, et al.
Publicado: (2021)

Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
por: Merritt, Kate, et al.
Publicado: (2019)

F180. CANNABINOID 1 RECEPTOR AVAILABILITY & MEMORY FUNCTION IN FIRST EPISODE PSYCHOSIS: A MULTI-MODAL PET-FMRI STUDY
por: Borgan, Faith, et al.
Publicado: (2018)

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis
por: Merritt, Kate, et al.
Publicado: (2013)

Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls
por: McCutcheon, Robert A., et al.
Publicado: (2021)

Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis
por: Egerton, Alice, et al.
Publicado: (2017)

N-Methyl-D-Aspartate Receptor binding in First-Episode Psychosis: A PET brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

An automatic analysis framework for FDOPA PET neuroimaging
por: Nordio, Giovanna, et al.
Publicado: (2023)

M18. REDUCED CORTICAL CEREBRAL BLOOD FLOW IN FIRST EPISODE PSYCHOSIS PATIENTS
por: Selvaggi, Pierluigi, et al.
Publicado: (2020)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species
por: Borgan, Faith, et al.
Publicado: (2019)

Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
por: Pillinger, Toby, et al.
Publicado: (2019)

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study
por: Borgan, Faith, et al.
Publicado: (2020)

Reduced cortical cerebral blood flow in antipsychotic-free first-episode psychosis and relationship to treatment response
por: Selvaggi, Pierluigi, et al.
Publicado: (2023)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
por: Colizzi, Marco, et al.
Publicado: (2019)

Correction: Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S., et al.
Publicado: (2018)

Correction: Regulation of dopaminergic function: An [(18)F]-DOPA PET apomorphine challenge study in humans
por: Jauhar, S, et al.
Publicado: (2019)

Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans.
por: Jauhar, S, et al.
Publicado: (2017)

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
por: McCutcheon, Robert, et al.
Publicado: (2018)

Adversity in childhood linked to elevated striatal dopamine function in adulthood
por: Egerton, Alice, et al.
Publicado: (2016)

Comparative Effects of Antipsychotics on Metabolic and Endocrine Function in Children and Young People With Schizophrenia: A Systematic Review and Network Meta-Analysis
por: Rogdaki, Maria, et al.
Publicado: (2023)

A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function
por: D’Ambrosio, Enrico, et al.
Publicado: (2022)

M163. GLUTAMATE METABOLITES ARE ASSOCIATED WITH ALTERED HIPPOCAMPAL ACTIVATION BUT NOT HIPPOCAMPAL-STRIATAL CONNECTIVITY IN SUBJECTS WITH A CLINICAL HIGH RISK FOR PSYCHOSIS
por: Hird, Emily, et al.
Publicado: (2020)

A potential biomarker for treatment stratification in psychosis: evaluation of an [(18)F] FDOPA PET imaging approach
por: Veronese, Mattia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e91chn4ajndpv2c1feenhnb9a9